Molecules / Iopromide

Iopromide API manufacturers

CAS 73334-07-3 ATC V08AB05 Updated 9 July 2026
5
manufacturers with an active filing 5 of them hold a US DMF or a CEP
40
shortage records on file across 2 countries
82
finished-dose makers across 43 regulators
Showing 5 of 5 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Bayer S/A

Brazil
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for iopromide, filing since 1989. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 46 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
46 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Bayer

Germany
Makes the APIFinished dose

Holds 2 valid CEPs for iopromide, filing since 2022. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 22 markets.

US DMF
None on file
CEP
2 valid
Last FDA inspection
2024 · VAI
GMP recognised in
22 markets
How this listing is sourced EDQM certificate database
EDQM certificate database
View profile
03

Zhejiang Starry Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for iopromide, filing since 2025. Its 2024 FDA inspection closed as NAI.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile

2 more manufacturers hold filings for iopromide

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Alp Pharm BeijingSuzhou Ryway Biotech
Open the full list with a free account

Finished-dose makers (7)

Bayer HealthCare United States Bracco Imaging Italy GE Healthcare Norway Guerbet France Jodas Expoim India Daewoong South Korea Novell Pharmaceutical Laboratories Indonesia

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map iopromide for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 40 Finished dose 7 Contract mfrs 0

By country

China 5